Atrandi Biosciences Secures Funding and Advances Global Commercialization of Next-Gen Single Cell Analysis Technology
● €4.5 million funding from Vsquared Ventures, Practica Capital and Metaplanet, bringing total funding to €8 million; ● New capital will support a worldwide commercial organisation, enabling a direct U.S. presence; ● Launch of new semi-permeable capsule technology to unlock breakthroughs in scientific discovery and innovation. VILNIUS, Lithuania and DENVER, CO, March 23, 2023 –…